Integrated Nano-Trojan Horse Protocol for Restoring Cellular Communication in Solid Tumors: A Disruptive Conceptual Framework

Background: Solid tumors present formidable therapeutic challenges due to metabolic reprogramming (Warburg effect) and disrupted intercellular communication networks. Conventional cytolytic approaches often fail to address foundational mechanisms of tumor autonomy. Objective: This conceptual paper introduces a novel integrative framework—Nano-Enabled Communication Restoration (NECR)—merging insulin-targeted nanotechnology with near-infrared (NIR)-activated immunomodulation to restore disrupted cellular communication in solid tumors. Methods: We propose a unified mathematical framework with explicit model hierarchy: (1) baseline growth dynamics (Gompertz, logistic, von Bertalanffy); (2) spatial invasion and transport (Fisher-KPP, advection-diffusion); (3) vascular-tumor coupling (Hahnfeldt extension); and (4) treatment-integrated stochastic core. The NECR protocol employs insulin-conjugated nanoparticles (20–100 nm, zeta potential -10 to +10 mV pH-switchable) as Trojan horses to deliver ECM-restorative enzymes and NIR-sensitive modulators. Treatment effects are explicitly incorporated via receptor-limited drug kinetics, pH-triggered release (Henderson-Hasselbalch), photobiomodulation terms, and immune reactivation components. Synthetic data validation follows TCGA-BRCA distributions with hierarchical Bayesian uncertainty quantification and global Sobol sensitivity analysis. Results: In silico Monte Carlo simulations (n=100 runs) under idealized modeling assumptions predict substantial tumor growth suppression, with simulated reductions reaching as high as 96–99.8% in idealized simulations at days 40–100 compared to untreated controls. These theoretical upper bounds reflect synergistic mechanisms but require empirical validation. Global sensitivity analysis identifies drug efficacy and NIR potency as dominant parameters, supporting targeted optimization priorities. Conclusions: NECR offers a theoretically rigorous, mechanistically grounded framework for remission induction through nano-light synergy. While experimental validation remains pending, the enhanced mathematical formalism, comprehensive parameterization, and proposed verification roadmap provide a robust foundation for translational development. All derivations, code, and synthetic datasets are provided for reproducibility. The framework is designed to be modular and adaptable to other solid tumors by substituting subtype-specific parameters. Keywords: Cancer therapy; Nanotechnology; Cellular communication; NIR photobiomodulation; Mathematical modeling; Tumor angiogenesis; Bayesian inference; Synthetic data validation研究背景：实体瘤因代谢重编程（沃伯格效应(Warburg effect)）与细胞间通讯网络紊乱，其治疗面临极大挑战。传统溶细胞疗法往往难以靶向解决肿瘤自主性的核心机制。 研究目的：本概念性论文提出一种全新的整合性框架——纳米介导通讯修复(Nano-Enabled Communication Restoration, NECR)，将靶向胰岛素的纳米技术与近红外(NIR)激活的免疫调节手段相结合，以恢复实体瘤中紊乱的细胞间通讯。 研究方法：本文提出一套包含明确模型层级的统一数学框架：(1) 基础生长动力学模型（冈珀茨模型、逻辑斯蒂模型、冯·贝塔朗菲模型）；(2) 空间侵袭与运输模型（费希尔-科勒-彼得森(Fisher-KPP)模型、平流扩散模型）；(3) 血管-肿瘤耦合模型（哈恩费尔特拓展模型(Hahnfeldt extension)）；(4) 整合治疗的随机核心模块。NECR治疗方案采用胰岛素偶联纳米颗粒（粒径20~100 nm，ζ电位(zeta potential)-10~+10 mV，pH响应型）作为特洛伊木马，递送细胞外基质修复酶与近红外敏感调节剂。治疗效应通过受体限制性药物动力学、pH触发释放（亨德森-哈塞尔巴尔赫方程(Henderson-Hasselbalch)）、光生物调节项以及免疫再激活组分进行显性建模。合成数据验证采用匹配TCGA-BRCA数据集的分布，并结合分层贝叶斯不确定性量化与全局索伯敏感性分析。 研究结果：基于理想化建模假设的计算机模拟(In silico)蒙特卡洛模拟（n=100次运行）结果显示，实体瘤生长可得到显著抑制；在理想化模拟中，与未处理对照组相比，第40~100天时肿瘤体积模拟降幅最高可达96%~99.8%。该理论上限反映了协同作用机制，但仍需实验验证。全局敏感性分析结果表明，药物效力与近红外效能为主导参数，可为靶向优化提供优先级参考。 研究结论：NECR框架通过纳米-光协同作用诱导肿瘤缓解，具备理论严谨性与机制依托性。尽管仍需开展实验验证，但本研究完善的数学形式化体系、全面的参数化方案与提出的验证路线图，为转化开发提供了坚实基础。所有推导过程、代码与合成数据集均已公开，以确保研究可重复性。该框架设计为模块化结构，可通过替换亚型特异性参数适配其他实体瘤类型。 关键词：癌症治疗；纳米技术；细胞间通讯；近红外光生物调节；数学建模；肿瘤血管生成；贝叶斯推断；合成数据验证